CHANTAL SULLIVAN: Open Payments
NPI 1740811280 · GULFPORT, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,576 in 78 payments from 12 companies in 2025. Trend: 2023 $1,215 · 2024 $1,673 · 2025 $1,576
Food & beverage: $1,576
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 14 | $374 |
| ABBVIE INC. | 19 | $287 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $208 |
| Supernus Pharmaceuticals, Inc. | 9 | $154 |
| Vanda Pharmaceuticals Inc. | 5 | $112 |
| Janssen Pharmaceuticals, Inc | 6 | $110 |
| Corium, LLC | 4 | $90 |
| E.R. Squibb & Sons, L.L.C. | 4 | $86 |
| Alkermes, Inc. | 3 | $65 |
| Lundbeck LLC | 2 | $40 |
Products named: Auvelity, VRAYLAR, CAPLYTA, Qelbree, FANAPT, SPRAVATO, Azstarys, COBENFY.
Industry payments across MS — which companies pay providers there.
